Navigation Links
ThermoGenesis Announces Sale of BioArchive Systems In Asia as Company Increases Presence In Key Market
Date:8/30/2010

RANCHO CORDOVA, Calif., Aug. 30 /PRNewswire/ -- ThermoGenesis Corp. (Nasdaq: KOOLD), a leading supplier of innovative products and services that process and store adult stem cells, said today it has sold two BioArchive® Systems to HealthBanks Biotech Company, Ltd. (HealthBanks).

HealthBanks, which operates cord blood banks in Taiwan, Hong Kong, Thailand and the U.S., now has a total of 20 BioArchives and a storage capacity for cryopreserving and archiving cord blood stem cells of 60,000 units.  HealthBanks also utilizes ThermoGenesis' AXP® AutoXpress™ (AXP) Platform, an automated device used for the processing of cord blood.  

"We are pleased with our continued strengthening relationship with HealthBanks, as well as with the increased penetration in Asia.  The region represents an important market opportunity for the Company as cord blood collection activity there is experiencing dramatic growth," noted J. Melville Engle, Chief Executive Officer of ThermoGenesis.

"We believe that the high cell recovery and viability achieved with the combined use of the AXP and BioArchive Systems plays a significant role in accelerating the time to patient engraftment," according to HealthBank's President Chang Hsiu-kang and Vice President of Operations Chen, Wei-Chun.

"We have a nearly decade-long relationship with HealthBanks and they are demonstrating the value of integrating our offerings -- the BioArchive and AXP -- as well as our manual bag sets, to create a model for the efficient and cost-effective collection of stem cells from cord blood that provides them the quality product and competitive advantages in the growing markets they serve," Engle noted.

"As we announced previously, the prior quarter was marked by strong BioArchive activity and we are encouraged that this trend appears to be continuing in the current quarter as
'/>"/>

SOURCE ThermoGenesis Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal 2008 on September 9, 2008
2. ThermoGenesis Reports Record Quarterly Revenues of $7.2 Million; Full Year Revenues Increase 31 Percent
3. ThermoGenesis Announces Distribution Agreement for Bone Marrow Stem Cell Device
4. ThermoGenesis Corp. to Announce First Quarter Fiscal 2009 Results on November 6, 2008
5. ThermoGenesis Presentation at Rodman & Renshaw Conference
6. ThermoGenesis Corp. to Announce Second Quarter Fiscal 2009 Results on February 4, 2009
7. ThermoGenesis Says FDA Concurs with Plan for Previously Announced AXP(TM) Bagset Recall
8. ThermoGenesis Announces Abstracts to Be Presented at Upcoming Stem Cell Therapy Conference
9. ThermoGenesis Provides Update on Fiscal 2009 Results
10. ThermoGenesis Announces Expanded Collaboration With Celling Technologies
11. ThermoGenesis Reports Fourth Quarter and Fiscal 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... MabVax Therapeutics Holdings, Inc. (OTCQB: MBVX) aclinical ... lead antibody, HuMab 5B1, will be garnering major attention ... upcoming World Molecular Imaging Congress (WMIC) being held in ... from the Department of Radiology at Memorial Sloan Kettering ... of MabVax,s lead antibody as a PET imaging agent ...
(Date:8/31/2015)... DUBLIN , Aug. 31, 2015 Research ... of the "Israel Biomedical Sensors Market - Growth, ... The Israel Biomedical Sensors market is ... of 3.73% over the period 2014-2020 The ... to the genetic formulation of each individual. These sensors ...
(Date:8/31/2015)... TORONTO , Aug. 31, 2015 /PRNewswire/ - Portage ... Canadian Securities Exchange: PBT.U), is pleased to announce that ... be advancing its lead candidate, PPL-003, to an Investigational ... dry eye disease and uveitis.  PPL recently completed a ... where topical PPL-003 solution achieved highly significant efficacy and ...
(Date:8/31/2015)... SHANGHAI , Aug. 31, 2015  MicuRx ... antibiotics, today announced positive top-line results from the ... drug candidate MRX-I. MRX-I is an oral oxazolidinone ... MRSA and VRE, while offering physicians and patients ... currently available oxazolidinone agents. "These ...
Breaking Biology Technology:MabVax Therapeutics HuMab 5B1 Antibody Is Highlighted at Upcoming World Molecular Imaging Congress in Five Separate Presentations 2MabVax Therapeutics HuMab 5B1 Antibody Is Highlighted at Upcoming World Molecular Imaging Congress in Five Separate Presentations 3MabVax Therapeutics HuMab 5B1 Antibody Is Highlighted at Upcoming World Molecular Imaging Congress in Five Separate Presentations 4Israel Biomedical Sensors Market 2015 - Growth, Trends & Forecasts to 2020 2Portage's PPL will advance its lead candidate PPL-003 to an IND for dry eye disease and uveitis 2Portage's PPL will advance its lead candidate PPL-003 to an IND for dry eye disease and uveitis 3MicuRX Reports Positive Top-Line Results In Phase 2 Clinical Trial For Novel Antibiotic MRX-I In Complicated Skin And Soft Tissue Infections 2
... EMERYVILLE, Calif., Sept. 12 Bionovo, Inc.,(Nasdaq: BNVI ... of safe and effective drugs in the areas of ... Chairman and CEO, and Dr.,Mary Tagliaferri, President and Chief ... Curhan Ford,s 5th annual Investor Summit on,September 15, 2008 ...
... /PRNewswire-FirstCall/ - The Board of Directors of,Neptune ... decided,not to re-price any options including the ... directors., About Neptune Technologies, Neptune ... for nutraceutical and pharmaceutical applications and is,sponsoring ...
... launched its revolutionary Trusted LASIK Surgeons directory service and ... a resource for consumers seeking to improve their vision. ... a unique screening process ensuring that only those who ... Surgeons in the United States are listed. Refractive eye ...
Cached Biology Technology:Bionovo to Present at Merriman Curhan Ford's Investor Summit 2008 on September 15th 2Bionovo to Present at Merriman Curhan Ford's Investor Summit 2008 on September 15th 3Neptune Technologies decided not to re-price options 2Trusted LASIK Surgeons Welcomes Leading LASIK Eye Surgery Expert, Inventor David Huang, M.D., Los Angeles, to Its Unique Lasik Directory Service 2Trusted LASIK Surgeons Welcomes Leading LASIK Eye Surgery Expert, Inventor David Huang, M.D., Los Angeles, to Its Unique Lasik Directory Service 3Trusted LASIK Surgeons Welcomes Leading LASIK Eye Surgery Expert, Inventor David Huang, M.D., Los Angeles, to Its Unique Lasik Directory Service 4Trusted LASIK Surgeons Welcomes Leading LASIK Eye Surgery Expert, Inventor David Huang, M.D., Los Angeles, to Its Unique Lasik Directory Service 5Trusted LASIK Surgeons Welcomes Leading LASIK Eye Surgery Expert, Inventor David Huang, M.D., Los Angeles, to Its Unique Lasik Directory Service 6Trusted LASIK Surgeons Welcomes Leading LASIK Eye Surgery Expert, Inventor David Huang, M.D., Los Angeles, to Its Unique Lasik Directory Service 7
(Date:9/1/2015)... MOUNTAIN VIEW, Calif. , Sept. 1, 2015 ... interaction with travelers during airport passenger screening. This ... which the passenger screening process will become unintrusive. ... and pre-clearance based on voluntary background investigations will ... analysis from Frost & Sullivan, Global Airport ...
(Date:8/31/2015)... 31, 2015 Growing need for ... government digitization projects to drive India ... TechSci Research report, " India Biometrics Market Forecast & Opportunities, ... is projected to grow at a CAGR of over 35% ... on account of extensive use of biometric technology in the ...
(Date:8/31/2015)... Research and Markets ( http://www.researchandmarkets.com/research/st5b3m/saudi_arabia ) has ... Sensors Market - Growth, Trends & Forecasts (2014-2020)" ... Arabia Biomedical Sensors market is estimated at $0.23 billion ... period 2014-2020 The near future will bring ... of each individual. These sensors can be set to ...
Breaking Biology News(10 mins):The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 2The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 3The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 4India Biometrics Market to Grow at Over 35% Through 2020, Says TechSci Research 2India Biometrics Market to Grow at Over 35% Through 2020, Says TechSci Research 3Saudi Arabia Biomedical Sensors Market Report 2015 - Growth, Trends & Forecasts (2014-2020) 2
... at the Monell Center, fruit flies are more like humans ... any other species. The diverse range of ... sweet to other species. For example, aspartame, a sweetener used ... However, fruit flies respond positively to most sweeteners ...
... method for creating synthetic life forms are at risk ... unless patent systems are brought into the 21st century, an ... Rimmer from the ANU College of Law takes a broad ... property rights and biological inventions in his new book ...
... Lung Cancer Partnership, in partnership with the LUNGevity Foundation, ... annual research grant competition. The research grants, ... lung cancer biology, risk assessment, prevention, detection, and response ... our very generous donors, were able to offer researchers ...
Cached Biology News:Like sweets? You're more like a fruit fly than you think... 2Biotechnology needs 21st century patent system: Expert 2National Lung Cancer Partnership and LUNGevity Foundation 2
RABBIT ANTI HUMAN CHYMOTRYPSIN...
... Captivate magnetic separator for six ... in conjunction with the Captivate ... or other magnetic particles and ... microcentrifuge tubes. Cell Biology Cell ...
This issue concentrated on the purification of proteins for specific purposes (i.e. large-scale purification, purification for therapeutic use, etc.)...
... Dunbar (1994) • This book describes ... methods for preparing samples for protein ... radiometric and bioluminescence-enhanced detection systems are ... the detection and characterization of glycoprotein ...
Biology Products: